IndraLab

Statements



reach
"We observed that SCN5A blocking dibenzazepines, but not the cardiac specific inhibitor flecainide, also enhanced killing of intracellular M.bovis BCG (Fig XREF_FIG), with no adverse cytotoxic effects (Supplementary FigS5), suggesting that SCN5A might be the molecular target of CBZ on macrophages."